Secondary vaccine effects
Preprint: The spike protein shedding that Pfizer warned about in their documentation to the FDA seems to have shown up at my clinic. Here is a retrospective study on the data that I collected.
© Colleen Huber, NMD
Primary vs secondary effects of medical treatment
Whereas the primary effects of a medical treatment involve the person receiving the procedure or medication, secondary effects are signs and symptoms in individuals who are close to the patient. Secondary effects are of such concern that, for example, if a cancer patient receives permanent radioactive implants, such as radioactive “seeds,” pregnant women and small children are generally advised to maintain a distance for two months or to avoid close contact of more than a few minutes.  
Primary effects of adverse events following COVID vaccines have been documented at the Vaccine Adverse Event Reporting System (VAERS) of the US Department of Health and Human Services.  Under court order  following FOIA request,  Pfizer released information to the FDA regarding primary adverse events following COVID vaccines.  The list shows approximately 1,500 different kinds of adverse conditions, totaling 158,893 “events” that were observed following administration of the COVID vaccines. Some of these conditions are known to be permanently disabling and/or life-threatening.
Here is a screenshot of the top part of the first page of that alphabetical list:
Secondary effects of the COVID vaccines have been observed in family members and co-workers of people who recently received COVID vaccines. Much of this information has been censored, after informal discussions of these phenomena on social media. 
Pfizer had acknowledged to the FDA that spike protein shedding from recently vaccinated people could occur by means of exhalation and skin contact, and that such exposure is “reportable to Pfizer Safety within 24 hours of investigator awareness.” 
A small retrospective study of secondary vaccine side effects
In my naturopathic medical clinic in Arizona, 26 people reported temporally associated reactions following exposure to COVID-vaccinated people. This was a minority of the patients being currently seen at the clinic. The following data thus comprise a retrospective case series of patients who reported symptoms after visiting or working with COVID-vaccinated people.
The ages of the affected individuals are from 5 to 80 years, and of both genders, and of multiple races.
The raw data is seen in the table below, in order of month of first exposure, where 1 = January, 2021; 2 = February, 2021, etc.
We can see from the above raw data that the preponderance of secondary effects occurred in the spring of 2021, which was a time of high COVID vaccine uptake in the US. That distribution is shown in the following graph:
None of the 26 individuals complained of initial reactions from February to March, or from August to October of 2021, nor since December 2021 to the present. This likely corresponds to a time when most of those who wanted COVID vaccines had received them, and then again a much smaller spike when boosters were widely available. The one first response in November, a severe and sudden hypertensive spike, occurred following a gathering of suburban seniors in which the subject was present. This was a time of known recent booster uptake. One other subject had symptoms near that time, a 68 year old male (line 19) in the first table, who had first had hypertension, which was unusual for him, in June 2021, and then again in December 2021, after booster uptake among those close to him.
Type of signs and symptoms reported
The following are the major signs and symptoms, and the number of patients with each:
Menstrual irregularities: 7
Post-menopausal menstrual-type symptoms: 6
Fatigue and / or malaise 5
Seizure and fever 1
The preponderance of menstrual symptoms among the signs and symptoms experienced is consistent with known increased concentration of spike proteins in ovaries over other organs. In this study of zebrafish inoculated with spike proteins, a disorganized extracellular matrix in the ovarian stroma was observed. 
In our clinic, after documenting the reported exposures and signs and symptoms of each individual, we treated them in accordance with a patient-doctor consult culminating in unpressured agreement on appropriate treatment. Patient preference determined which of the following of the doctors’ suggestions were followed, and some treatments had been chosen before consult, i.e. ibuprofen, pine needle tea and acetaminophen.
N Acetyl Cysteine 12
Pine needle tea 2
Vitamin C 1
These add up to more than the 26 patients of the affected cohort, because most chose multiple strategies.
Regarding avoidance, one moved to a very rural area, and has now found relief there; the symptoms had been so intense as to warrant moving from a suburban community.
A retrospective assessment
At this writing, none of the above still report symptoms on questioning, although most have chosen to stop, or to not bother much with, the interventions above. This fast decline in previous symptoms reported, as well as lack of new symptoms reported, and lack of resorting to remedies for the same, suggests that COVID vaccination has not proceeded at such an intense pace following the spring of 2021, and it also suggests that the incidence of spike protein shedding from the vaccinated has slowed or stopped. Another possibility for the lack of reported symptoms since spring 2021 could be habituation or tolerance in the unvaccinated population to spike protein shedding from the vaccinated population.
 American Society of Clinical Oncology (ASCO). Cancer.net. Understanding radiation therapy. https://www.cancer.net/navigating-cancer-care/how-cancer-treated/radiation-therapy/understanding-radiation-therapy
 Cancer Research UK. Internal radiotherapy safety. https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/radiotherapy/internal/safety
 Aaron Siri. VDA produces the first 91+ pages of documents from Pfizer’s COVID-19 vaccine file. Nov 19 2021.
 Siri Glimstad. Freedom of information Act Request to the Food and Drug Administration. Aug 27 2021. https://phmpt.org/wp-content/uploads/2021/10/IR0546-FDA-Pfizer-Approval-FINAL.pdf
 Pfizer Worldwide Safety. 5.3.6 Cumulative analysis of post-authorization adverse event reports of PF-07302048 (BNT162B2) received through 28-Feb-2021. Appendix 1: List of adverse events of special interest. https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf
 Naomi Wolf had begun to gather informal reports from individuals on social media regarding menstrual irregularities in family members of recently vaccinated people. Before that information was consolidated or analyzed, she was suspended from Twitter. This BBC article is too biased to attain credibility, but gives the key event of discussing vaccine secondary effects and the June 5-6, 2021 timeframe of Wolf’s suspension from Twitter, which is close in time to peak incidence of secondary effects in this study. https://www.bbc.com/news/world-us-canada-57374241 None of the prominent MSM smear articles on the event of Wolf’s suspension from Twitter reveal any attempt to interview Wolf, and one of her detractors claims that he “took an hour on the internet” to refute her, leaving the reader no confidence in the veracity of such articles. https://www.businessinsider.com/whos-afraid-of-naomi-wolf-2021-6 It is possible that the empirical data that Wolf had begun to gather may be lost permanently.
 Pfizer. A Phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS-CoV-2 RNA vaccine candidates against COVID-19 in healthy individuals. Pp. 67-68. https://cdn.pfizer.com/pfizercom/2020-11/C4591001_Clinical_Protocol_Nov2020.pdf
 B Ventura, et al. Toxicity of spike fragments of SARS-CoV-2 S protein for zebrafish: A tool to study its hazardous for human health. Sci Total Environ. Mar 20 2022. https://pubmed.ncbi.nlm.nih.gov/34942250/